z-logo
open-access-imgOpen Access
Inhibition of the Clostridioides difficile Class D β-Lactamase CDD-1 by Avibactam
Author(s) -
Nichole K. Stewart,
Márta Tóth,
Anastasiya Stasyuk,
Mijoon Lee,
Clyde A. Smith,
Sergei B. Vakulenko
Publication year - 2021
Publication title -
acs infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.324
H-Index - 39
ISSN - 2373-8227
DOI - 10.1021/acsinfecdis.0c00714
Subject(s) - avibactam , enzyme , microbiology and biotechnology , bacteria , chemistry , beta lactamase inhibitors , gram negative bacteria , gram , biology , stereochemistry , biochemistry , enterobacteriaceae , genetics , escherichia coli , gene
Avibactam is a potent diazobicyclooctane inhibitor of class A and C β-lactamases. The inhibitor also exhibits variable activity against some class D enzymes from Gram-negative bacteria; however, its interaction with recently discovered class D β-lactamases from Gram-positive bacteria has not been studied. Here, we describe microbiological, kinetic, and mass spectrometry studies of the interaction of avibactam with CDD-1, a class D β-lactamase from the clinically important pathogen Clostridioides difficile , and show that avibactam is a potent irreversible mechanism-based inhibitor of the enzyme. X-ray crystallographic studies at three time-points demonstrate the rapid formation of a stable CDD-1-avibactam acyl-enzyme complex and highlight differences in the anchoring of the inhibitor by class D enzymes from Gram-positive and Gram-negative bacteria.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom